Localised chronic fibroedematous gingivitis treated with chamomile-argan oil in patients aged 15-19 years

An experimental study with pre-test, post-test, and a control group was conducted to evaluate the effectiveness of chamomile-argan oil in the treatment of chronic fibroedematous gingivitis in patients at the Martha Machado Cuní Teacher Training Centre between 2020 and 2022. The study population consisted of students aged 15-19 years old at the centre. The population consisted of students diagnosed with some type of gingivitis, and the sample consisted of 68 students diagnosed with localised chronic fibroedematous gingivitis. The aim of this study was to evaluate the effectiveness of chamomile-argan oil in the treatment of localised chronic fibroedematous gingivitis. The variables considered were sex, age groups, presence of chronic fibroedematous gingivitis and effectiveness of chamomile-argan oil. After obtaining informed consent, a thorough interview and clinical examination was carried out on each of the patients who took part in the research in order to achieve the proposed objective. Chronic localised fibroedematous gingivitis was predominant in the population. The study sample was predominantly female, aged between 15 and 16 years, with a diet rich in sugar, poor oral hygiene and hormonal changes as risk factors associated with the onset of gingivitis. Chamomile-argan oil is effective in the treatment of localised chronic fibro-oedematous gingivitis. Taking into account the shortage of medicines in Cuba, the effectiveness of the proposed treatment, and the guidelines established in Cuban state policy, it can be argued that the use of the proposed treatment is highly significant and timely. It would therefore be essential to recommend the production of chamomile-argan oil for the treatment of localised chronic fibro-oedematous gingivitis, as well as for other pathologies affecting the stomatognathic system.